INS and Hypoglycemia: In fact, the combination of GLP-1 RA with basal insulin therapy causes a strong reduction in HbA1c and insulin dose reduction weight loss, and the combination of SGLT2i with insulin also effectively reduces HbA1c, insulin dose, and hypoglycemia and promotes weight loss [150].